Pershing Square USA (PSUS) holder keeps 10.1M shares after sale

Cyrille Bolloré, CEO of Bolloré SE, urged Universal Music Group to reject Bill Ackman’s $64 billion takeover bid, saying the price is “not there” and that the offer relies on company cash, according to Reuters. Bolloré controls 18.4% of UMG and Vivendi 13.4%, giving them blocking power. Ackman said Bolloré’s stake is key and proposed shifting UMG’s listing to NYSE.

Bill Ackman’s Pershing Square USA closed-end fund raised $5 billion, priced at $50 per share, according to Renaissance Capital and other reports. The offering combined a registered public offering ($2.2 billion) and private placement ($2.8 billion). Reuters said it was among the largest recent IPOs for a closed-end fund. The vehicle is designed to provide “permanent capital” without redemption pressure.

SFL Corporation ordered two 93,000 cbm ammonia carriers for $216 million, deliverable in 2028. The company also secured long-term charters with an oil major, adding $162 million to its backlog. CEO Ole B. Hjertaker highlighted the investment's accretive nature and the charterer's investment-grade status. The total fixed-rate charter backlog for 2026 exceeds $1.3 billion.

Chevron (CVX) announced senior leadership changes effective January 1, 2027. Mark Nelson will focus on strategy and business development, Eimear Bonner will lead Oil, Products & Gas, Jeff Gustavson will become CFO, and Brent Gros will head New Energies and AI strategy. CEO Mike Wirth praised the new leaders' expertise and commitment.

Ultragenyx Pharmaceutical (NASDAQ: RARE) agreed to sell a rare pediatric disease priority review voucher for $210M, nearly half its cash reserves. The deal, subject to regulatory approval, follows the FDA's August approval of its Genglycos gene therapy. Shares rose 2.97% on the news. Ultragenyx plans to use proceeds to advance rare disease therapies and support profitability. The price is within the range of recent voucher transactions, such as Rocket Pharmaceuticals' $180M deal.

Warren Buffett and Berkshire Hathaway each report owning 12.5% of Lennar Corporation's Class A shares, totaling 26,034,436 shares with shared voting and dispositive power. National Indemnity Company holds 10.3%, or 21,502,349 shares. Other Berkshire affiliates also report significant stakes.